Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Apr. 30, 2020
Apr. 30, 2019
Apr. 30, 2020
Apr. 30, 2019
Income Statement [Abstract]        
Revenue
Expenses:        
Research and development 6,103,163 4,222,193 17,586,220 13,708,168
General and administrative 3,731,517 2,691,796 15,617,958 9,189,293
Loss from operations (9,834,680) (6,913,989) (33,204,178) (22,897,461)
Other income, net 54,908 113,360 182,019 333,665
Interest expense (987) (1,070) (987)
Foreign currency exchange (loss) gain, net (108,409) (77,965) (257,010) (185,967)
Realized loss on sale of securities, net (12,134)
Loss before income taxes (9,888,181) (6,879,581) (33,280,239) (22,762,884)
Provision for income taxes 3,520 2,450 10,860
Net loss $ (9,888,181) $ (6,883,101) $ (33,282,689) $ (22,773,744)
Basic and diluted net loss per common share $ (0.45) $ (1.03) $ (2.31) $ (3.71)
Weighted average shares used in computing basic and diluted net loss per common share 21,953,087 6,664,863 [1] 14,383,027 6,146,676 [1]
[1] On May 20, 2019, the Company effected a 1 for 10 reverse stock split. Shares have been retroactively restated.